A potential impurity found in commercial preparations of darifenacin
Related Products
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Darifenacin N-oxide

Item No. 35083

Technical Information
Formal Name
1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-3-pyrrolidineacetamide, 1-oxide
CAS Number
2416229-88-2
Molecular Formula
C28H30N2O3
Formula Weight
Purity
≥90%
A solid
SMILES
NC(C(C1C[N+](CCC2=CC=C(OCC3)C3=C2)([O-])CC1)(C4=CC=CC=C4)C5=CC=CC=C5)=O
InChi Code
InChI=1S/C28H30N2O3/c29-27(31)28(23-7-3-1-4-8-23,24-9-5-2-6-10-24)25-14-17-30(32,20-25)16-13-21-11-12-26-22(19-21)15-18-33-26/h1-12,19,25H,13-18,20H2,(H2,29,31)
InChi Key
NWHZIKCUBJRZEN-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Product Description

    Darifenacin N-oxide is a potential impurity found in commercial preparations of the muscarinic acetylcholine receptor (mAChR) antagonist darifenacin.1 It is a degradation product formed under oxidative conditions.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Thomas, S., Paul, S.K., Shandilya, S., et alIdentification and structural elucidation of two process impurities and stress degradants in darifenacin hydrobromide active pharmaceutical ingredient by LC-ESI/MSn. Analyst 137(15), 3571-3582 (2012).